While total protein levels and processing of proSP-C(I73T) were not consistently altered, perhaps related to the nature and proteostasis status of the cells, our work supports the concept that altering SP-C(I73T) trafficking route by EMC3/VCP inhibition is sufficient to minimize damage to AT2 cells and thus to ameliorate ILD. This evidence concerns the gene EMC3 and interstitial lung disease.